Skip to Content

M L71 (Letrozole 2.5 mg)

Pill imprint M L71 has been identified as Letrozole 2.5 mg.

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Letrozole 2.5 mg M L71
Letrozole 2.5 mg M L71
Discount Card Promo
Letrozole
Imprint:
M L71
Strength:
2.5 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2071
Inactive Ingredients:
silicon dioxide
D&C Red No. 27
FD&C Blue No. 2
FD&C Red No. 40
hypromelloses
lactose anhydrous
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
triacetin

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide